Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Huntington Bancshares Incorporated (HBAN) Price & Performance

GE HealthCare Technologies Inc. Common StockTrade
Huntington Bancshares IncorporatedTrade

Price performance (Past 24H)

Key statistics

GE HealthCare Technologies Inc. Common Stock vs Huntington Bancshares Incorporated — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while Huntington Bancshares Incorporated trades at $15.11 (market cap $30.79B). The key difference: GE HealthCare Technologies Inc. Common Stock and Huntington Bancshares Incorporated are close in size by market cap, and Huntington Bancshares Incorporated pays the higher dividend (4.07%). Which is the better fit depends on your goals.

GEHCHBAN
Market Cap
$31.07B$30.79B
Volume
3,443,02016,522,211
Sector
HealthFinancials
52-Week High
$88.16$19.27
52-Week Low
$59.48$15.02
Enterprise Value
$39.53B$49.31B
Dividend Yield
0.23%4.07%
Typical Hold Time
—52 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GE HealthCare Technologies Inc. Common Stock

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

Huntington Bancshares Incorporated

Huntington Bancshares (HBAN) trades at $15.10, down 1.95% amid bearish technical signals and recent earnings volatility. The stock shows mixed fundamentals with a P/E of 11.72 and ROE of 9.23%, while revenue grew to $8.13B in 2025. Recent news highlights margin pressures from higher interest rates and a reduced 2027 outlook, though the company maintains shareholder returns through dividends and buybacks.

HBAN presents a cautious near-term outlook with analyst consensus at $19.60 (30% upside potential) but faces headwinds from net interest margin compression. Investment opportunity lies in valuation discount to peers, while risks include prolonged rate pressures and execution challenges in loan growth. The balanced analyst rating (47% Buy, 47% Hold) reflects uncertainty around timing of recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GEHC

No sentiment data available yet.

HBAN
83% Buy17% Sell
Avg holding period · 52 Days

Top news

Latest headlines on both assets

About GE HealthCare Technologies Inc. Common Stock

GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.

Read more on GEHC →

About Huntington Bancshares Incorporated

Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.

Read more on HBAN →